Cannabinoid receptors as novel targets for the treatment of melanoma

No abstract is available for this paper.

• Publication year

  2006

• Venue

  The FASEB Journal

• Publication date

  2006-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1096/fj.06-6638fjePMID 17065222
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme

  2006cited by this paper
• Use of human tissue to assess the oncogenic activity of melanoma-associated mutations

  2005cited by this paper
• Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.

  2005cited by this paper
• Cannabinoid-based drugs as anti-inflammatory therapeutics

  2005cited by this paper
• Melanoma genetics and the development of rational therapeutics.

  2005cited by this paper
• Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells

  2005cited by this paper
• Activation of AKT kinases in cancer: implications for therapeutic targeting.

  2005cited by this paper
• Cannabinoids and cancer: causation, remediation, and palliation.

  2005cited by this paper
• Cutaneous melanoma.

  2005cited by this paper
• Long-term effects of exposure to cannabis.

  2005cited by this paper
• Cannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in Gliomas

  2004cited by this paper
• Management of cutaneous melanoma.

  2004cited by this paper
• Deregulated Akt3 Activity Promotes Development of Malignant Melanoma

  2004cited by this paper
• Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling.

  2003cited by this paper
• Differential Roles of CB1 and CB2 Cannabinoid Receptors in Mast Cells1

  2003cited by this paper
• Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors.

  2003cited by this paper
• International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels

  2003cited by this paper
• The genetics of malignant melanoma: lessons from mouse and man

  2003cited by this paper
• Pharmacokinetics and Pharmacodynamics of Cannabinoids

  2003cited by this paper
• Inhibition of tumor angiogenesis by cannabinoids

  2003cited by this paper
• Cannabinoids: potential anticancer agents

  2003cited by this paper
• The molecular logic of endocannabinoid signalling

  2003cited by this paper
• PTEN signaling pathways in melanoma

  2003cited by this paper
• International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors

  2002cited by this paper
• Targeting the endocannabinoid system in cancer therapy: A call for further research

  2002cited by this paper
• Cannabinoids Promote Oligodendrocyte Progenitor Survival: Involvement of Cannabinoid Receptors and Phosphatidylinositol-3 Kinase/Akt Signaling

  2002cited by this paper
• Cannabinoids Protect Astrocytes from Ceramide-induced Apoptosis through the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway*

  2002cited by this paper
• Induction of Nod2 in Myelomonocytic and Intestinal Epithelial Cells via Nuclear Factor-κB Activation*

  2002cited by this paper
• De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis.

  2002cited by this paper
• To cycle or not to cycle: a critical decision in cancer

  2001cited by this paper
• Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review

  2001cited by this paper
• Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor.

  2001cited by this paper
• Control by the endogenous cannabinoid system of ras oncogene‐dependent tumor growth

  2001cited by this paper
• Functional CB1 cannabinoid receptors in human vascular endothelial cells.

  2000influential reference
• The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt.

  2000cited by this paper
• The CB(1) cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase.

  2000cited by this paper
• Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation

  2000cited by this paper
• Requirement for Activation of the Serine-Threonine Kinase Akt (Protein Kinase B) in Insulin Stimulation of Protein Synthesis but Not of Glucose Transport

  1998cited by this paper
• Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the Delta9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes.

  1998cited by this paper
• Control of pain initiation by endogenous cannabinoids

  1998cited by this paper
• Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression.

  1996influential reference
• Toxicity and carcinogenicity of delta 9-tetrahydrocannabinol in Fischer rats and B6C3F1 mice.

  1996cited by this paper
• Toxicity and Carcinogenicity of Δ9-Tetrahydrocannabinol in Fischer Rats and B6C3F1 Mice

  1996cited by this paper
• Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1.

  1995influential reference
• Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.

  1995cited by this paper
• Cutaneous melanoma.

  1993cited by this paper
• Isolation and structure of a brain constituent that binds to the cannabinoid receptor.

  1992cited by this paper
• Molecular oncology

  1991cited by this paper
• Antineoplastic activity of cannabinoids.

  1975cited by this paper
• Identification functional characterization of brainstem cannabinoid CB2 receptors.

  year unknowncited by this paper
• The FASEB Journal express article 10.1096/fj.02-0795fje. Published online January 2, 2003. Inhibition of tumor angiogenesis by cannabinoids

  year unknowncited by this paper

• Integrated Computational Investigation of Cannabis sativa Phytoconstituents as Putative Multi-Target Inhibitors in Skin Cancer: A Molecular Docking, Dynamics, and ADMET Profiling Study.

  2026cites this paper
• Cannabinoids and the autophagy-related signaling in brain Tumors: From mechanistic insights to therapeutic Frontiers in glioblastoma.

  2026cites this paper
• Pharmacokinetic studies and synergistic antitumor effects of cannabichromene and cannabidiol in drug-resistant breast cancers.

  2026cites this paper
• THC and CBD Induce Heme Oxygenase-1-Dependent Cell Death and Trigger Mitochondrial Dysfunction in Human Melanoma and Cutaneous Squamous Cell Carcinoma Cells

  2026cites this paper
• The Role of the Endocannabinoid System in Oncology and the Potential Use of Cannabis Derivatives for Cancer Management in Companion Animals

  2025cites this paper
• Research mapping of cannabinoids and endocannabinoid system in cancer over the past three decades: insights from bibliometric analysis

  2025cites this paper
• Endocrine Controls of Skin Aging.

  2025cites this paper
• Distribution of endocannabinoid system receptors in the equine hoof: dysregulation as a potential therapeutic target for laminitis

  2025cites this paper
• Revealing the therapeutic potential of synthetic cannabinoids: a systematic review of cannabinoid receptor binding dynamics and their implications for cancer therapy

  2025influential citation
• The anti-inflammatory and analgesic potential of the probiotic Streptococcus thermophilus via inhibition of endocannabinoid-degrading enzymes: a preliminary in vitro study

  2025cites this paper
• Bioinformatics differential expression analysis of the effect of cannabidiol in chronic myeloid leukaemia cell line

  2025influential citation
• Cannabidiol in Skin Health: A Comprehensive Review of Topical Applications in Dermatology and Cosmetic Science

  2025cites this paper
• Pro-Apoptotic Effects of Anandamide in Human Gastric Cancer Cells Are Mediated by AKT and ERK Signaling Pathways

  2025cites this paper
• The Endocannabinoid System: Implications in Gastrointestinal Physiology and Pathology

  2025cites this paper
• Drug repurposing opportunities for breast cancer and seven common subtypes.

  2024cites this paper
• In the weeds: A comprehensive review of cannabis; its chemical complexity, biosynthesis, and healing abilities

  2024cites this paper
• Recent Research Trends Against Skin Carcinoma - An Overview.

  2024cites this paper
• Exploring the therapeutic potential of cannabinoids in cancer by modulating signaling pathways and addressing clinical challenges

  2024cites this paper
• The Potential Role of Cannabidiol in Cosmetic Dermatology: A Literature Review

  2024cites this paper
• Arachidonoylethanolamide promotes cellular senescence in a human glioblastoma cell line.

  2024cites this paper
• Exploring the Potential of Synthetic Cannabinoids: Modulation of Biological Activity of Normal and Cancerous Human Colon Epithelial Cells

  2024cites this paper
• β-Caryophyllene Inhibits Endothelial Tube Formation by Modulating the Secretome of Hypoxic Lung Cancer Cells—Possible Role of VEGF Downregulation

  2024cites this paper
• Anti-Cancer and Anti-Proliferative Potential of Cannabidiol: A Cellular and Molecular Perspective

  2024cites this paper
• Melanoma and cannabinoids: A possible chance for cancer treatment

  2024cites this paper
• Antiproliferative effects of LY-2183240 combined with various chemotherapeutic drugs in an isobolographic in vitro model of malignant melanoma.

  2024cites this paper
• The Effect of Cannabis Plant Extracts on Head and Neck Squamous Cell Carcinoma and the Quest for Cannabis-Based Personalized Therapy

  2023cites this paper
• AM1172 (a hydrolysis-resistant endocannabinoid analog that inhibits anandamide cellular uptake) reduces the viability of the various melanoma cells, but it exerts significant cytotoxic effects on healthy cells: an in vitro study based on isobolographic analysis

  2023cites this paper
• Cannabinoids and Their Receptors in Skin Diseases

  2023cites this paper
• Cannabinoids Reduce Melanoma Cell Viability and Do Not Interfere with Commonly Used Targeted Therapy in Metastatic Melanoma In Vivo and In Vitro

  2023cites this paper
• A comprehensive review on novel targeted therapy methods and nanotechnology-based gene delivery systems in melanoma.

  2023cites this paper
• Rationalizing a prospective coupling effect of cannabinoids with the current pharmacotherapy for melanoma treatment.

  2023cites this paper
• Cannabidiol and Minor Phytocannabinoids: A Preliminary Study to Assess Their Anti-Melanoma, Anti-Melanogenic, and Anti-Tyrosinase Properties

  2023cites this paper
• Gene Profiling of Cannabis-sativa-mediated Apoptosis in Human Melanoma Cells

  2023cites this paper
• Anti-proliferative and apoptotic effect of cannabinoids on human pancreatic ductal adenocarcinoma xenograft in BALB/c nude mice model

  2023cites this paper
• Anticancer properties of cannabidiol and Δ9-tetrahydrocannabinol and synergistic effects with gemcitabine and cisplatin in bladder cancer cell lines

  2023cites this paper
• Neuronal Cannabinoid CB1 Receptors Suppress the Growth of Melanoma Brain Metastases by Inhibiting Glutamatergic Signalling

  2023cites this paper
• Cannabinoids and the placenta: Receptors, signaling and outcomes.

  2023cites this paper
• Targeting Fatty Acid Amide Hydrolase Counteracts the Epithelial-to-Mesenchymal Transition in Keratinocyte-Derived Tumors

  2023cites this paper
• Phytochemical Constituents and Derivatives of Cannabis sativa; Bridging the Gap in Melanoma Treatment

  2023cites this paper
• N-adamantyl-anthranil amide derivatives: New selective ligands for the cannabinoid receptor subtype 2 (CB2R).

  2023cites this paper
• Cannabinoid-Based Medicines as Cancer Therapy

  2022cites this paper
• Targeting the Endocannabinoid System: From the Need for New Therapies to the Development of a Promising Strategy. What About Pancreatic Cancer?

  2022cites this paper
• Anti-cancer properties of cannflavin A and potential synergistic effects with gemcitabine, cisplatin, and cannabinoids in bladder cancer

  2022cites this paper
• Synthetic cannabinoid WIN 55,212–2 inhibits growth and induces cell death of oral and pancreatic stem-like/poorly differentiated tumor cells

  2022cites this paper
• Interaction of Glia Cells with Glioblastoma and Melanoma Cells under the Influence of Phytocannabinoids

  2022cites this paper
• Small Molecule Compounds of Natural Origin Target Cellular Receptors to Inhibit Cancer Development and Progression

  2022cites this paper
• Investigation of the Effects of the Endogenous Cannabinoid Anandamide on Luminal A Breast Cancer Cell Line MCF-7.

  2022cites this paper
• Impact of Cannabinoid Compounds on Skin Cancer

  2022influential citation
• Use of Cannabis and Cannabinoids for Treatment of Cancer

  2022cites this paper
• Cannabinoids as anticancer drugs: current status of preclinical research

  2022cites this paper
• PREPARATION AND CHARACTERIZATION OF FULL-SPECTRUM CANNABIS EXTRACT LOADED POLY(THIOETHER-ESTER) NANOPARTICLES: IN VITRO EVALUATION OF THEIR ANTITUMORAL EFFICACY

  2022cites this paper
• Role of classical cannabinoid receptors in cancer-associated bone disease

  2022cites this paper
• Cannabis as a potential compound against various malignancies, legal aspects, advancement by exploiting nanotechnology and clinical trials

  2022cites this paper
• Expression of cannabinoid receptors CB1 and CB2 in canine cutaneous mast cell tumours.

  2022cites this paper
• Evaluation of the local and circulating expression level of cannabinoid receptor 2 in patients with lung cancer

  2022cites this paper
• The Synthetic Cannabinoid URB447 Exerts Antitumor and Antimetastatic Effect in Melanoma and Colon Cancer

  2022cites this paper
• The cannabinoid receptors system in horses: Tissue distribution and cellular identification in skin

  2022cites this paper
• Delivering therapeutic cannabinoids via skin: Current state and future perspectives.

  2021cites this paper
• Neuroendocrine Factors in Melanoma Pathogenesis

  2021cites this paper
• New Insights on Hemp Oil Enriched in Cannabidiol: Decarboxylation, Antioxidant Properties and In Vitro Anticancer Effect

  2021cites this paper
• Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma

  2021cites this paper
• Cannabinoids in the landscape of cancer

  2021cites this paper
• Therapeutic potential of cannabinoids in combination cancer therapy.

  2021cites this paper
• Human epithelial stem cell survival within their niche requires “tonic” cannabinoid receptor 1‐signalling—Lessons from the hair follicle

  2021cites this paper
• Cannabinoids pharmacological effects are beyond the palliative effects: CB2 cannabinoid receptor agonist induced cytotoxicity and apoptosis in human colorectal cancer cells (HT-29)

  2021cites this paper
• Cannabinoids and their derivatives in struggle against melanoma

  2021cites this paper
• Repurposing Cannabidiol as a Potential Drug Candidate for Anti-Tumor Therapies

  2021cites this paper
• Cannabinoids in Dermatologic Surgery.

  2021cites this paper
• Cannabinoids as anticancer and neuroprotective drugs: Structural insights and pharmacological interactions—A review

  2021cites this paper
• The Endocannabinoid System as a Pharmacological Target for New Cancer Therapies

  2021cites this paper
• Cannabis Extracts and Their Cytotoxic Effects on Human Erythrocytes, Fibroblasts, and Murine Melanoma

  2021cites this paper
• Cannabinoids and Breast Cancer

  2021cites this paper
• Synthesis Of Pyrazoline Fatty Chain Derivatives And Its Effects On Melanoma Cells.

  2021cites this paper
• Anti-cancer properties of cannabidiol and Δ9-tetrahydrocannabinol and potential synergistic effects with gemcitabine, cisplatin and other cannabinoids in bladder cancer

  2021cites this paper
• Cannabis and the skin.

  2021cites this paper
• Cannabinoids in Oncology and Immune Response

  2021cites this paper
• Corrigendum: Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents

  2021cites this paper
• Anticancer property of Hemp Bioactive Peptides in Hep3B liver cancer cells through Akt/GSK3β/β‐catenin signaling pathway

  2021cites this paper
• Pharmacological Properties, Therapeutic Potential and Molecular Mechanisms of JWH133, a CB2 Receptor-Selective Agonist

  2021cites this paper
• THC Reduces Ki67-Immunoreactive Cells Derived from Human Primary Glioblastoma in a GPR55-Dependent Manner

  2021cites this paper
• A Novel Mechanism of Cannabidiol in Suppressing Hepatocellular Carcinoma by Inducing GSDME Dependent Pyroptosis

  2021cites this paper
• Endocannabinoid System and Tumour Microenvironment: New Intertwined Connections for Anticancer Approaches

  2021cites this paper
• Molecular Mechanism of Autophagy and Its Regulation by Cannabinoids in Cancer

  2021cites this paper
• Tetrahydrocannabinol and Skin Cancer: Analysis of YouTube Videos

  2020cites this paper
• CB1R regulates soluble leptin receptor levels via CHOP, contributing to hepatic leptin resistance

  2020cites this paper
• Anti-Cancer Potential of Cannabinoids, Terpenes, and Flavonoids Present in Cannabis

  2020influential citation
• Roles of Cannabinoids in Melanoma: Evidence from In Vivo Studies

  2020cites this paper
• ReviewCannabidiol (CBD) as a Promising Anti-Cancer DrugEmily S. Seltzer 1

  2020influential citation
• Pharmacology of Endocannabinoids and Their Receptors

  2020cites this paper
• "AM251, a cannabinoid receptor 1 antagonist, prevents human fibroblasts differentiation and collagen deposition induced by TGF-β - an in vitro study."

  2020cites this paper
• Cannabis, the Endocannabinoid System and Immunity—the Journey from the Bedside to the Bench and Back

  2020cites this paper
• Cannabis and its Constituents for Cancer: History, Biogenesis, Chemistry and Pharmacological Activities.

  2020cites this paper
• A new role for anandamide: defective link between the systemic and skin endocannabinoid systems in hypertrophic human wound healing

  2020cites this paper
• Cutaneous endocannabinoid system: Does it have a role on skin wound healing bearing fibrosis?

  2020cites this paper
• Cannabis in Dermatology

  2020cites this paper
• Oleamide Induces Cell Death in Glioblastoma RG2 Cells by a Cannabinoid Receptor–Independent Mechanism

  2020cites this paper
• Cannabidiol (CBD) as a Promising Anti-Cancer Drug

  2020cites this paper
• Mechanisms of Cannabinoids and Potential Applicability to Skin Diseases

  2020cites this paper
• Cannabinoids in the Pathophysiology of Skin Inflammation

  2020cites this paper
• The role of cannabinoids in the treatment of cancer.

  2020influential citation